HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach
- 13 November 2008
- journal article
- research article
- Published by Taylor & Francis Ltd in AIDS Care
- Vol. 20 (10), 1161-1168
- https://doi.org/10.1080/09540120701855375
Abstract
This study examined HIV vaccine acceptability among immigrant Thai residents in Los Angeles, California. We combined a qualitative research method (focus groups) with an innovative market research method (conjoint analysis). Focus groups explored social issues, concerns, barriers and motivators associated with HIV vaccine acceptability. Conjoint analysis was used to assess preferences among eight hypothetical HIV vaccines with varying attribute profiles and the impact of various attributes on acceptability. Five main themes were identified in the focus groups regarding acceptance and utilization of preventive HIV vaccines: (1) vaccine characteristics, such as efficacy, physical side-effects and cost, (2) fear of a vaccine, (3) vaccine acceptability and optimism, (4) social and family responses and (5) behavioral disinhibition. Conjoint analysis revealed HIV vaccine acceptability ranging from 7.4 (SD = 19.4) to 85.2 (SD = 24.3) across eight hypothetical vaccines. The vaccine with the highest acceptability had the following attributes: 99% efficacy, no side-effects, 10 years of protection, protects against one sub-type, free, one dose and given by injection. Vaccine efficacy had the greatest impact on acceptability (51.4, p=.005), followed by side-effects (11.1, p=.005) and duration of protection (8.3, p=.005). Despite some apprehensions and concerns, Thai residents perceived an HIV vaccine as making an important contribution to society and to protecting oneself and one's family from HIV infection. Nevertheless, acceptability of a partially efficacious vaccine may be low, suggesting the need for tailored social marketing interventions that might emphasize a collectivistic rather than an individualistic focus. Assessing HIV vaccine acceptability using a mixed-method approach is feasible with Thai residents and should lend itself to HIV vaccine research with other Asian Pacific Islander populations in the US.Keywords
This publication has 28 references indexed in Scilit:
- HIV vaccine trial preparedness among Spanish-speaking Latinos in the USAIDS Care, 2007
- Managing Shame and Stigma: Case Studies of Female Carers of People With AIDS in Southern ThailandQualitative Health Research, 2006
- Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trialBritish Journal of Dermatology, 2006
- The private demand for an AIDS vaccine in ThailandHealth Policy, 2005
- Challenges for HIV Vaccine Dissemination and Clinical Trial Recruitment: If We Build It, Will They Come?AIDS Patient Care and STDs, 2004
- HIV risk and prevention in a post-vaccine contextVaccine, 2004
- What Constitutes Efficacy for a Human Immunodeficiency Virus Vaccine that Ameliorates Viremia: Issues Involving Surrogate End Points in Phase 3 TrialsThe Journal of Infectious Diseases, 2003
- Measuring What People Value: A Comparison of “Attitude” and “Preference” SurveysHealth Services Research, 2002
- Factors Affecting African-American Participation in AIDS ResearchJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- The Roles of Altruism, Free Riding, and Bandwagoning in Vaccination DecisionsOrganizational Behavior and Human Decision Processes, 1994